Senior insider sale
Chief Operating Officer at GYRE THERAPEUTICS, INC. — senior position signals high conviction
$2.12M
300K shares
What this filing means
YE WEIGUO plans to sell 300K shares of GYRE THERAPEUTICS, INC. valued at approximately $2.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001985496-26-000001
Officer· Chief Operating Officer
Since Oct 2023
300K
Shares to sell
$2.12M
Approx. market value
300K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/24/2025
300KTotal acquired300K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/24/2025 | Stock Option Exercise Cash | 300K | — |
| Total | 300K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
300K
Market value
$2.12M
5/13/2026
Total
Units
300K
Value
$2.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/13/2026 | 300K | $2.12M | NASDAQ | Planned |
| Total | 300K | $2.12M | ||